Christopher Dolan, MD
Orthopaedic Surgery · Reno, NVNPI 1528277811
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Conformis, Inc. at 48.5% of the total. Reporting peaked in 2021 at $1,377 and has fallen 85.6% since, to $198 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NV, where the typical reported total is $3,547.
Across 15 payments — averaging $194.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$1K
- Sequoia Surgical, Inc.$1K
- Stryker$215
- Biom'up France SAS$63
- Argentum Medical$17
What the payments were for
- Speaking & faculty fees$91631%
- Travel & lodging$763%
- Food & beverage$73225%
- Education$1,20041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 6 | $1,418 |
| Sequoia Surgical, Inc. | 2 | $1,212 |
| Stryker | 5 | $215 |
| Biom'up France SAS | 1 | $63 |
| Argentum Medical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,925 in reported general payments places this provider in the 45th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 96 | $548 |
| Tramadol Hcl | 107 | $270 |
| Oxycodone Hcl | 53 | $267 |
| Celecoxib | 25 | $261 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $237 |
| Amoxicillin | 90 | $180 |
| Mupirocin | 16 | $105 |
| Meloxicam | 30 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Reno
- Hilary MalcarneyReno$189K
- Travis KieckbuschReno$54K
- Sean FitzpatrickReno$28K
- Sean SterrenbergReno$23K
- Babe WestlakeReno$17K
- Patrick BarousseReno$14K
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.